我院2011～2013年调节血脂药用药分析

摘要

Objective To analyze the status and development of the utilization of lipid regulating agents in our hospital .Methods A statistical analysis ,using the analysis of defined daily dose ,ordering of consumption sum ,DDDs and DDC ,was performed .Re‐sults The consumption sum of lipid regulating agents increased year by year ,the sum of lipid regulating agents from 2011 to 2013 were 3 029 200 ,4 515 500 ,and 5 241 600 yuan ,respectively .The increasing ratio of 2012 and 2013 was 49 .07% and 73 .04% ;st‐atins were the major lipid regulating agents used in our hospital .Conclusion The use of lipid regulating agents in our hospital was rational and in line with the clinical trend and treatment principle of lipid regulating agents .%目的：分析我院调节血脂药物应用的现状和发展趋势。方法采用限定日剂量（DDD ）法、销售金额排序法、用药频度（DDDs）和药品限定日费用（DDC）分析法，对我院2011～2013年调节血脂药品的使用进行统计分析。结果我院调节血脂药物销售金额逐年增长，2011～2013年降血脂药销售总金额分别是3029200，4515500和5241600元；与2011年相比，2012年和2013年平均年增长率分别为49．07％和73．04％；他汀类是主要的调节血脂药。结论我院调节血脂药的临床应用基本合理，符合国内临床降血脂药用药趋势及治疗原则。